Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
316.63
-0.77 (-0.24%)
At close: Jun 26, 2026, 4:00 PM EDT
316.63
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:00 PM EDT
Penumbra Employees
Penumbra had 4,700 employees as of December 31, 2025. The number of employees increased by 200 or 4.44% compared to the previous year.
Employees
4,700
Change (1Y)
200
Growth (1Y)
4.44%
Revenue / Employee
$309,422
Profits / Employee
$36,393
Market Cap
12.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | 200 | 4.44% |
| Dec 31, 2024 | 4,500 | 300 | 7.14% |
| Dec 31, 2023 | 4,200 | 300 | 7.69% |
| Dec 31, 2022 | 3,900 | 100 | 2.63% |
| Dec 31, 2021 | 3,800 | 500 | 15.15% |
| Dec 31, 2020 | 3,300 | 600 | 22.22% |
| Dec 31, 2019 | 2,700 | 500 | 22.73% |
| Dec 31, 2018 | 2,200 | 500 | 29.41% |
| Dec 31, 2017 | 1,700 | 200 | 13.33% |
| Dec 31, 2016 | 1,500 | 400 | 36.36% |
| Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| DexCom | 11,100 |
| Bruker | 11,085 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
PEN News
- 12 days ago - Penumbra secured CE Mark in Europe for Thunderbolt - TheFly
- 12 days ago - Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT - PRNewsWire
- 16 days ago - Penumbra receives FDA clearance for Thunderbolt - TheFly
- 16 days ago - Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke - PRNewsWire
- 6 weeks ago - Soros buys Penumbra, exits Take-Two in Q1 - TheFly
- 7 weeks ago - Penumbra price target lowered to $335 from $345 at Evercore ISI - TheFly
- 7 weeks ago - Penumbra price target lowered to $350 from $374 at Citi - TheFly
- 7 weeks ago - Penumbra reports Q1 EPS 82c, consensus $1.06 - TheFly